
CREATe Therapeutics announces in vivo proof-of-concept results of their small molecule-controlled gene therapy platform
CREATe Therapeutics announces in vivo proof-of-concept results of their small molecule-controlled gene therapy platform, encouraging further development LEIDEN, NETHERLANDS, March 6, 2025 /EINPresswire.com/ -- CREATe Therapeutics (CREATe Tx), a …